Bendamustine Combined with Bortezomib Has Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study

被引：0
|
作者：
Berenson, James R.
Yellin, Ori
Bessudo, Alberto [1 ]
Boccia, Ralph V. [2 ]
Noga, Stephen J. [3 ]
Gravenor, Donald S. [4 ]
Patel-Donnelly, Dipti [5 ]
Siegel, Robert S. [6 ]
Kewalramani, Tarun [7 ]
Gorak, Edward J. [8 ]
Swift, Regina A. [9 ]
Mayo, Debra [10 ]
机构：
[1] San Diego Pacific Oncol Hematol Associates Inc, Encinitas, CA USA
[2] Ctr Canc & Blood Disorders, Bethesda, MD USA
[3] Weinberg Canc Inst Franklin Sq, Sect Hematol, Baltimore, MD USA
[4] Family Canc Ctr, Memphis, TN USA
[5] Virginia Canc Specialists PC, Fairfax, VA USA
[6] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[7] Lahey Clin Med Ctr, Burlington, MA 01803 USA
[8] Geisinger Med Ctr, Danville, PA 17822 USA
[9] James R Berenson MD Inc, Los Angeles, CA USA
[10] Cephalon Inc, Frazer, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：808 / 809
页数：2
相关论文
共 50 条
  • [11] A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma
    Yoshiaki Ogawa
    Michinori Ogura
    Kensei Tobinai
    Kiyoshi Ando
    Tatsuya Suzuki
    Takashi Watanabe
    Ken Ohmachi
    Toshiki Uchida
    Mary E. Hanson
    Yoshinobu Tanaka
    Yasuhiro Koh
    Takashi Shimamoto
    Tomomitsu Hotta
    International Journal of Hematology, 2016, 103 : 25 - 33
  • [12] A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma
    Ogawa, Yoshiaki
    Ogura, Michinori
    Tobinai, Kensei
    Ando, Kiyoshi
    Suzuki, Tatsuya
    Watanabe, Takashi
    Ohmachi, Ken
    Uchida, Toshiki
    Hanson, Mary E.
    Tanaka, Yoshinobu
    Koh, Yasuhiro
    Shimamoto, Takashi
    Hotta, Tomomitsu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (01) : 25 - 33
  • [13] A PHASE 1B STUDY OF VENETOCLAX COMBINED WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Moreau, P.
    Chanan-Khan, A.
    Roberts, A. W.
    Agarwal, A. B.
    Facon, T.
    Kumar, S.
    Touzeau, C.
    Cordero, J.
    Ross, J.
    Munasinghe, W.
    Jia, J.
    Salem, A. H.
    Leverson, J.
    Maciag, P.
    Verdugo, M.
    Harrison, S. J.
    HAEMATOLOGICA, 2017, 102 : 169 - 169
  • [14] A Phase 1b Study of Venetoclax Combined with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Moreau, Philippe
    Chanan-Khan, Asher
    Roberts, Andrew W.
    Agarwal, Amit B.
    Facon, Thierry
    Kumar, Shaji
    Touzeau, Cyrille
    Cordero, Jaclyn
    Ross, Jeremy
    Munasinghe, Wijith
    Jia, Jia
    Salem, Ahmed H.
    Leverson, Joel
    Maciag, Paulo
    Verdugo, Maria
    Harrison, Simon J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E16 - E16
  • [15] COMBINED VORINOSTAT AND BORTEZOMIB IN BORTEZOMIB-REFRACTORY PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INTERIM ANALYSIS OF A PHASE IIB STUDY
    Siegel, D.
    Jagannath, S.
    Lonial, S.
    Dimopoulos, M.
    Yoon, S. S.
    Graef, T.
    Pitrangelo, D.
    Lupinacci, L.
    Reiser, D.
    Anderson, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 156 - 157
  • [16] A Phase I Study of Bendamustine Combined with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma.
    Lentzsch, Suzanne
    O'Sullivan, Amy
    Lalo, Silvana
    Kruppa, Carrie
    Gardner, Diane
    Kennedy, Ryan C.
    Burt, Steve
    Mapara, Markus Y.
    Redner, Robert
    Roodman, David
    Volkin, Robert L.
    Zonder, Jeffrey
    BLOOD, 2009, 114 (22) : 736 - 736
  • [17] Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial.
    Berenson, J. R.
    Yellin, O.
    Bessudo, A.
    Boccia, R.
    Noga, S.
    Gravenor, D.
    Patel-Donnelly, D.
    Siegel, R. S.
    Kewalramani, T.
    Gorak, E. J.
    Swift, R.
    Bensen-Kennedy, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [18] Bendamustine in patients with relapsed or refractory multiple myeloma
    M Michael
    I Bruns
    E Bölke
    F Zohren
    A Czibere
    N N Safaian
    F Neumann
    R Haas
    G Kobbe
    R Fenk
    European Journal of Medical Research, 15
  • [19] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [20] Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study
    Richardson, Paul G.
    Chanan-Khan, Asher A.
    Lonial, Sagar
    Krishnan, Amrita Y.
    Carroll, Michael P.
    Alsina, Melissa
    Albitar, Maher
    Berman, David
    Messina, Marianne
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 729 - 740
12345